Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment

Mirogabalin (DS‐5565) is a novel preferentially selective α(2)δ‐1 ligand being developed for the treatment of diabetic peripheral neuropathic pain and postherpetic neuralgia. The current multicenter open‐label study determined the effect of varying degrees of renal impairment on the pharmacokinetics...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Pharmacol
Main Authors: Kato, Manabu, Tajima, Naoyuki, Shimizu, Takako, Sugihara, Masahiro, Furihata, Kenichi, Harada, Kazuhiro, Ishizuka, Hitoshi
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2017
Assuntos:
Special Populations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5763271/
https://ncbi.nlm.nih.gov/pubmed/28834546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.974
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares